Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective

Polygenic scores strongly predict type 1 diabetes risk, but most scores were developed in European-ancestry populations. In this study, we developed a multi-ancestry polygenic score to accurately predict type 1 diabetes risk across diverse populations.

Research Design and Methods

We used recent multi-ancestry genome-wide association studies to create a type 1 diabetes multi-ancestry polygenic score (T1D MAPS). We trained the score in the Mass General Brigham (MGB) Biobank (372 individuals with type 1 diabetes) and tested the score in the All of Us program (86 individuals with type 1 diabetes). We evaluated the area under the receiver operating characteristic curve (AUC), and we compared the AUC to two published single-ancestry scores: T1D GRS2 EUR and T1D GRS AFR . We also developed an updated score (T1D MAPS2) that combines T1D GRS2 EUR and T1D MAPS.

Results

Among individuals with non-European ancestry, the AUC of T1D MAPS was 0.90, significantly higher than T1D GRS2 EUR (0.82, P = 0.04) and T1D GRS AFR (0.82, P = 0.007). Among individuals with European ancestry, the AUC of T1D MAPS was slightly lower than T1D GRS2 EUR (0.89 vs. 0.91, P = 0.02). However, T1D MAPS2 performed equivalently to T1D GRS2 EUR in European ancestry (0.91 vs. 0.91, P = 0.45) while still performing better in non-European ancestry (0.90 vs. 0.82, P = 0.04).

Conclusions

A novel polygenic score improves type 1 diabetes risk prediction in non-European ancestry while maintaining high predictive power in European ancestry. These findings advance the accuracy of type 1 diabetes genetic risk prediction across diverse populations.

Article Highlights

  • Why did we undertake this study?

    Type 1 diabetes polygenic scores are highly predictive of disease risk, but their performance varies based on genetic ancestry.

  • What is the specific question(s) we wanted to answer?

    Can we develop a polygenic score that accurately predicts type 1 diabetes risk across diverse populations?

  • What did we find?

    Our novel polygenic score performs similarly to existing scores in European populations, and it demonstrates superior performance in non-European populations.

  • What are the implications of our findings?

    This polygenic score will improve prediction of type 1 diabetes risk in genetically diverse populations.

Article activity feed